Montelukast Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with montelukast
S
- Saizen (somatropin)
- Scemblix (asciminib)
- Se-Donna PB HYOS (atropine / hyoscyamine / phenobarbital / scopolamine)
- secobarbital
- Seconal Sodium (secobarbital)
- Sedapap (acetaminophen / butalbital)
- selpercatinib
- Septra (sulfamethoxazole / trimethoprim)
- Septra DS (sulfamethoxazole / trimethoprim)
- Septra IV (sulfamethoxazole / trimethoprim)
- Serostim (somatropin)
- Servira (atropine / hyoscyamine / phenobarbital / scopolamine)
- Sesquient (fosphenytoin)
- Sezaby (phenobarbital)
- Skyclarys (omaveloxolone)
- Skytrofa (lonapegsomatropin)
- SMZ-TMP DS (sulfamethoxazole / trimethoprim)
- sodium phenylbutyrate / taurursodiol
- Sogroya (somapacitan-beco)
- Solfoton (phenobarbital)
- Soltamox (tamoxifen)
- Solurex (dexamethasone)
- Solurex LA (dexamethasone)
- somapacitan-beco
- somatrem
- somatrogon
- somatropin
- sotorasib
- sparsentan
- Spasmolin (atropine / hyoscyamine / phenobarbital / scopolamine)
- Spasquid (atropine / hyoscyamine / phenobarbital / scopolamine)
- Spastrin (belladonna / ergotamine / phenobarbital)
- st. john's wort
- Starlix (nateglinide)
- Stavzor (valproic acid)
- sulfadiazine
- sulfamethizole
- sulfamethoxazole
- sulfamethoxazole / trimethoprim
- Sulfatrim (sulfamethoxazole / trimethoprim)
- Sulfatrim Pediatric (sulfamethoxazole / trimethoprim)
- sulfinpyrazone
- Sunlenca (lenacapavir)
- Sustiva (efavirenz)
- Symdeko (ivacaftor / tezacaftor)
- Symfi (efavirenz / lamivudine / tenofovir)
- Symfi Lo (efavirenz / lamivudine / tenofovir)
More about montelukast
- montelukast consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (564)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: leukotriene modifiers
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.